ADVFN US – Market Content Editor

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) reported third-quarter 2026 revenue of $243 million, compared with $157 million a year earlier, representing an increase of approximately 55%, supported by commercial product sales and revenue from research partnerships. The biotechnology company reduced its full-year sales guidance for TRYNGOLZA to approximately $50 million from $100 million to $110 million, citing…

Faeth Therapeutics (NASDAQ:FTH) reported preliminary Phase 2 clinical results showing a confirmed objective response rate of 33% for its investigational PIKTOR treatment combined with paclitaxel in patients with advanced endometrioid endometrial cancer. The biotechnology company also reported a disease control rate of 83% and preliminary median progression-free survival of 7.4 months in its ongoing PIK-201…

Zura Bio Limited (NASDAQ:ZURA) announced that its Phase 2 TibuSHIELD trial evaluating tibulizumab (ZB-106) in adults with moderate-to-severe hidradenitis suppurativa (HS) failed to meet its primary and key secondary efficacy endpoints. The biotechnology company said neither the 300 mg nor the 150 mg dose achieved the study’s primary endpoint of percentage change from baseline in…

Biomolecular Life Holdings, Inc. (USOTC:BIOM) announced that it has agreed to acquire land in Llanogrande, Rionegro, Colombia, for the development of a wellness and longevity retreat combining biomolecular technologies, personalised wellness programmes and hospitality services. The proposed facility will be located approximately 10 minutes from José María Córdova International Airport, which serves Medellín and the…

Amarin Corporation plc (NASDAQ:AMRN) presented new clinical and laboratory research examining the relationship between lipoprotein(a), or Lp(a), and cardiovascular risk at the American Heart Association (AHA) Scientific Sessions 2026 in Chicago. The findings included an analysis of cardiovascular outcomes among participants in the REDUCE-IT trial and laboratory experiments investigating the effects of eicosapentaenoic acid (EPA)…

American Fusion Inc. (USOTC:AMFN) announced that an independent third-party review of its Texatron Fusion Engine technology is underway, while the company also expects to complete the acquisition of a research and development facility in North Texas before November 26, 2026. The developments form part of American Fusion’s programme to advance its fusion energy technology and…

Artificial Intelligence Technology Solutions, Inc. (USOTC:AITX) announced that its wholly owned subsidiary, Robotic Assistance Devices (RAD), has introduced RAIA, a portable, solar-powered security tower designed for deployment without a trailer or specialised transportation equipment. The Remote Autonomous Intelligent Agent (RAIA) system is designed to ship in two parcels and can be installed by one person…

Delcath Systems, Inc. (NASDAQ:DCTH) reported third-quarter 2026 revenue of $35.1 million, an increase of approximately 70% from $20.6 million in the corresponding period last year, supported by higher sales of its liver cancer treatment products. The oncology company also raised its full-year revenue guidance to between $115 million and $117 million, reflecting continued growth in…

Heron Therapeutics, Inc. (NASDAQ:HRTX) reported net revenue of $35.3 million for the third quarter ended September 30, 2026, representing a 7.8% decline from $38.2 million in the corresponding period last year and a decrease from $37.7 million in the previous quarter. The biotechnology company reported growth in its Acute Care business, while revenue from its…

Powerfleet, Inc. (NASDAQ:AIOT) reported record revenue of $115.7 million for the second quarter of fiscal 2027, ended September 30, 2026, representing a 4% increase from $111.7 million a year earlier and 4% sequential growth. The AI-powered asset management technology company reported operating profit of $1.4 million, while adjusted EBITDA increased slightly to $24.9 million from…